Form 8-K - Current report:
SEC Accession No. 0001808665-24-000033
Filing Date
2024-08-07
Accepted
2024-08-07 16:04:10
Documents
15
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asrt-20240807.htm   iXBRL 8-K 32273
2 EX-99.1 asrtq22024earningsreleasee.htm EX-99.1 368102
6 image0a06.jpg GRAPHIC 3999
  Complete submission text file 0001808665-24-000033.txt   561502

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20240807.xsd EX-101.SCH 1910
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20240807_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20240807_pre.xml EX-101.PRE 13052
17 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20240807_htm.xml XML 2824
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 241183518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)